You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

DONEPEZIL HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Donepezil Hydrochloride, and when can generic versions of Donepezil Hydrochloride launch?

Donepezil Hydrochloride is a drug marketed by Chartwell Rx, Hisun Pharm Hangzhou, Macleods Pharms Ltd, Sandoz, Sun Pharm Industries, Unichem, Zydus Pharms Usa Inc, Accord Hlthcare, ACI, Actavis Elizabeth, Alembic Pharms Ltd, Apotex, Aurobindo, Cadila Pharms Ltd, Cipla Ltd, Dexcel, Dr Reddys, Dr Reddys Labs Ltd, Endo Operations, Heritage Pharma, Hetero Labs Ltd V, Hikma Pharms, Indicus Pharma, Jubilant Generics, Lupin Ltd, Natco Pharma, Osmotica Pharm Us, Prinston Inc, Rising, Sciegen Pharms Inc, Strides Pharma, Sun Pharm, Sun Pharm Inds, Sun Pharm Inds Ltd, Torrent Pharms, Twi Pharms, Wockhardt, Zydus Lifesciences, and Zydus Pharms. and is included in forty-seven NDAs.

The generic ingredient in DONEPEZIL HYDROCHLORIDE is donepezil hydrochloride. There are thirty-two drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the donepezil hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Donepezil Hydrochloride

A generic version of DONEPEZIL HYDROCHLORIDE was approved as donepezil hydrochloride by ACI on May 31st, 2011.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DONEPEZIL HYDROCHLORIDE?
  • What are the global sales for DONEPEZIL HYDROCHLORIDE?
  • What is Average Wholesale Price for DONEPEZIL HYDROCHLORIDE?
Drug patent expirations by year for DONEPEZIL HYDROCHLORIDE
Recent Clinical Trials for DONEPEZIL HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Duke UniversityPhase 2
NeuroSense Therapeutics Ltd.Phase 2
FundaciĆ³ Institut de Recerca de l'Hospital de la Santa Creu i Sant PauPhase 2

See all DONEPEZIL HYDROCHLORIDE clinical trials

Pharmacology for DONEPEZIL HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for DONEPEZIL HYDROCHLORIDE
Paragraph IV (Patent) Challenges for DONEPEZIL HYDROCHLORIDE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
ARICEPT Tablets donepezil hydrochloride 23 mg 022568 2013-07-09
ARICEPT ODT Orally Disintegrating Tablets donepezil hydrochloride 5 mg and 10 mg 021720 1 2010-06-30

US Patents and Regulatory Information for DONEPEZIL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Torrent Pharms DONEPEZIL HYDROCHLORIDE donepezil hydrochloride TABLET;ORAL 090686-001 May 31, 2011 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hetero Labs Ltd V DONEPEZIL HYDROCHLORIDE donepezil hydrochloride TABLET;ORAL 203034-002 Jan 30, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Cipla Ltd DONEPEZIL HYDROCHLORIDE donepezil hydrochloride TABLET;ORAL 077518-002 May 31, 2011 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lupin Ltd DONEPEZIL HYDROCHLORIDE donepezil hydrochloride TABLET;ORAL 202782-001 Oct 30, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rising DONEPEZIL HYDROCHLORIDE donepezil hydrochloride TABLET;ORAL 202656-001 Oct 22, 2015 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Indicus Pharma DONEPEZIL HYDROCHLORIDE donepezil hydrochloride TABLET;ORAL 201634-001 Jun 13, 2012 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Macleods Pharms Ltd DONEPEZIL HYDROCHLORIDE donepezil hydrochloride TABLET;ORAL 201146-001 Aug 17, 2012 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.